- Trials with a EudraCT protocol (4)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
4 result(s) found for: Xylitol.
Displaying page 1 of 1.
EudraCT Number: 2018-002311-10 | Sponsor Protocol Number: SCT-Cpx-004 | Start Date*: 2018-10-09 |
Sponsor Name:Swiss Cardio Technologies AG | ||
Full Title: A multi-center, open label, single group, observational study to investigate the effects of training on the administration of Cardioplexol (TM) | ||
Medical condition: Medical conditions with the need for an elective surgical coronary artery bypass grafting (CABG) and/or a valve repair/replacement . | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2009-016801-40 | Sponsor Protocol Number: IP-001-09 | Start Date*: 2016-01-26 | |||||||||||
Sponsor Name:IPERBOREAL PHARMA | |||||||||||||
Full Title: Efficacy and Safety assessments of a peritoneal dialysis solution containing Glucose, Xylitol and L-Carnitine compared to standard PD solutions in Continuous Ambulatory Peritoneal Dialysis (CAPD) | |||||||||||||
Medical condition: Patients with ESRD treated by CAPD | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2011-004198-10 | Sponsor Protocol Number: SCT-Cpx-003 | Start Date*: 2012-03-22 |
Sponsor Name:Swiss Cardio Technologies AG | ||
Full Title: A Single-Centre, Single Blind, Randomized, Active-Controlled Phase III Non-Inferiority Study to Investigate the Safety and Efficacy of the Cardioplegic Solution Cardioplexol when used during a Ca... | ||
Medical condition: Medical conditions necessitating an elective surgical coronary artery bypass grafting (CABG) and/or a valve repair/replacement. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2019-004183-21 | Sponsor Protocol Number: IP-001-18 | Start Date*: 2022-08-19 | |||||||||||
Sponsor Name:Iperboreal Pharma Srl | |||||||||||||
Full Title: A Study to Evaluate the EffIcacy and Safety of XyloCore, a Glucose Sparing Experimental Solution, for Peritoneal Dialysis | |||||||||||||
Medical condition: End-Stage Renal Disease (ESRD) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Trial now transitioned) IT (Trial now transitioned) DK (Trial now transitioned) ES (Ongoing) | |||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
